Open AccessLive birth outcomes from IVF treatments in younger patients with low AMH
Author(s) -
Masaya Miyagi,
Keiko Mekaru,
Rie Nakamura,
Sugiko Oishi,
Kozue Akamine,
Chiaki Heshiki,
Yoichi Aoki
Publication year - 2021
Publication title -
jbra
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 14
eISSN - 1518-0557
pISSN - 1517-5693
DOI - 10.5935/1518-0557.20210006
Subject(s) - live birth , anti müllerian hormone , medicine , ovarian reserve , in vitro fertilisation , pregnancy , gynecology , obstetrics , infertility , hormone , biology , genetics
Anti-Müllerian hormone (AMH) is used to predict in vitro fertilization outcomes. However, predicting live birth is difficult in younger patients with low AMH. Thus, this study aimed to determine the live birth rates from younger patients with low anti-Müllerian hormone levels.